NCT04572776 2021-11-09
Phase 3 Study to Assess Resiniferatoxin vs Standard of Care for the Treatment of Intractable Cancer Pain
Sorrento Therapeutics, Inc.
Phase 3 Withdrawn
Sorrento Therapeutics, Inc.
Norwegian University of Science and Technology
Alliance for Clinical Trials in Oncology
9305-9954 Quebec Inc
Cristália Produtos Químicos Farmacêuticos Ltda.
GOG Foundation
SWOG Cancer Research Network